GE HealthCare Technologies Debt to Equity Ratio 2020-2025 | GEHC
Current and historical debt to equity ratio values for GE HealthCare Technologies (GEHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GE HealthCare Technologies debt/equity for the three months ending September 30, 2025 was 0.83.
| GE HealthCare Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $26.11B | $10.02B | 2.61 |
| 2025-06-30 | $25.77B | $9.73B | 2.65 |
| 2025-03-31 | $24.38B | $9.21B | 2.65 |
| 2024-12-31 | $24.63B | $8.46B | 2.91 |
| 2024-09-30 | $25.52B | $8.34B | 3.06 |
| 2024-06-30 | $24.04B | $7.82B | 3.08 |
| 2024-03-31 | $24.79B | $7.42B | 3.34 |
| 2023-12-31 | $25.31B | $7.15B | 3.54 |
| 2023-09-30 | $25.24B | $7.14B | 3.53 |
| 2023-06-30 | $25.20B | $7.11B | 3.54 |
| 2023-03-31 | $25.94B | $6.70B | 3.87 |
| 2022-12-31 | $18.18B | $9.36B | 1.94 |
| 2022-09-30 | $9.19B | $16.88B | 0.54 |
| 2022-06-30 | $0.00B | $0.00B | 0.00 |
| 2022-03-31 | $0.00B | $0.00B | 0.00 |
| 2021-12-31 | $0.00B | 0.00 | |
| 2021-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $9.48B | $14.75B | 0.64 |
| 2019-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.337B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.790B | 20.86 |
| EssilorLuxottica (ESLOY) | France | $145.149B | 0.00 |
| Boston Scientific (BSX) | United States | $137.141B | 31.36 |
| Stryker (SYK) | United States | $135.776B | 26.96 |
| Medtronic (MDT) | Ireland | $129.330B | 17.92 |
| Medline (MDLN) | United States | $60.431B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.968B | 0.00 |
| Agilent Technologies (A) | United States | $38.287B | 24.20 |
| ResMed (RMD) | United States | $36.833B | 25.49 |
| Koninklijke Philips (PHG) | Netherlands | $28.310B | 18.49 |
| Terumo (TRUMY) | Japan | $20.239B | 22.78 |
| Insulet (PODD) | United States | $19.106B | 59.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.163B | 10.70 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.153B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.000B | 28.77 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.477B | 13.64 |
| BillionToOne (BLLN) | United States | $4.008B | 0.00 |
| Envista Holdings (NVST) | United States | $3.920B | 22.49 |
| ICU Medical (ICUI) | United States | $3.769B | 23.93 |
| Haemonetics (HAE) | United States | $3.221B | 14.34 |
| Prestige Consumer Healthcare (PBH) | United States | $3.164B | 14.43 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.132B | 46.67 |
| Perrigo (PRGO) | Ireland | $2.026B | 5.08 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.911B | 38.46 |
| QuidelOrtho (QDEL) | United States | $1.908B | 12.27 |
| Curaleaf Holdings (CURLF) | Canada | $1.839B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.672B | 73.27 |
| Phibro Animal Health (PAHC) | United States | $1.581B | 15.79 |
| Kestra Medical Technologies (KMTS) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.366B | 19.78 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.362B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.197B | 355.29 |
| Capricor Therapeutics (CAPR) | United States | $1.061B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.949B | 0.00 |
| InMode (INMD) | Israel | $0.882B | 9.96 |
| Omeros (OMER) | United States | $0.846B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.74 |
| Verano Holdings (VRNO) | United States | $0.519B | 0.00 |
| Cerus (CERS) | United States | $0.478B | 0.00 |
| Brainsway (BWAY) | Israel | $0.451B | 76.80 |
| Cresco Labs (CRLBF) | United States | $0.447B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.319B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.303B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 147.67 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.224B | 0.00 |
| High Tide (HITI) | Canada | $0.223B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.30 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.182B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Exagen (XGN) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 24.08 |
| Nephros (NEPH) | United States | $0.050B | 36.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Veru (VERU) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.10 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |